Mapping the genes for arylamine N-acetyltransferases

Mapping the genes for arylamine N-acetyltransferases

<p>Arylamine N-acetyltransferases are xenobiotic metabolising enzymes, involved in metabolic pathways leading to either detoxification or bio-activation of drugs and carcinogens. In humans, polymorphisms of the two functional NAT genes (<em>NAT1</em> and <em>NAT2</em>}...

Bibliografski detalji
Glavni autor:	Fakis, G
Format:	Disertacija
Izdano:	2000

Slični predmeti

Expression of the genes for arylamine N-acetyltransferases in mice
od: Boukouvala, S, i dr.
Izdano: (2002)

Structure and mechanism of arylamine N-acetyltransferases.
od: Westwood, I, i dr.
Izdano: (2006)

Description of a novel polymorphic gene encoding for arylamine N-acetyltransferase in the rhesus macaque (Macaca mulatta), a model animal for endometriosis.
od: Fakis, G, i dr.
Izdano: (2007)

Arylamine N-acetyltransferase in adult mouse brain
od: Mo, M, i dr.
Izdano: (2004)

Structural Studies on the Mycobacterial Arylamine N-Acetyltransferases
od: Abuhammad, A, i dr.
Izdano: (2010)

Arylamine N-acetyltransferase 2 gene polymorphism in an Algerian population
od: Hiba Chelouti, i dr.
Izdano: (2017-08-01)

Chromosome mapping of the genes for murine arylamine N-acetyltransferases (NATs), enzymes involved in the metabolism of carcinogens: identification of a novel upstream noncoding exon for murine Nat2.
od: Fakis, G, i dr.
Izdano: (2000)

Neuroendocrine expression of mouse arylamine N-acetyltransferase 2
od: Wakefield, L, i dr.
Izdano: (2006)

Arylamine N-acetyltransferases: structural and functional implications of polymorphisms.
od: Sim, E, i dr.
Izdano: (2008)

Humans and Chimpanzees Display Opposite Patterns of Diversity in Arylamine N-Acetyltransferase Genes
od: Christelle Vangenot, i dr.
Izdano: (2019-07-01)

Differences between murine arylamine N-acetyltransferase type 1 and human arylamine N-acetyltransferase type 2 defined by substrate specificity and inhibitor binding
od: Laurieri, N, i dr.
Izdano: (2014)

An approach to identifying novel substrates of bacterial arylamine N-acetyltransferases.
od: Brooke, E, i dr.
Izdano: (2003)

Arylamine N-acetyltransferase expression during murine heart development
od: Wakefield, L, i dr.
Izdano: (2004)

Biochemical Characterization of Arylamine N-acetyltransferases From Vibrio vulnificus
od: Xinning Liu, i dr.
Izdano: (2021-01-01)

Structural investigation of mutant Mycobacterium smegmatis arylamine N-acetyltransferase: a model for a naturally occurring functional polymorphism in Mycobacterium tuberculosis arylamine N-acetyltransferase.
od: Kawamura, A, i dr.
Izdano: (2003)

Selective small molecule inhibitors of the potential breast cancer marker, human arylamine N-acetyltransferase 1, and its murine homologue, mouse arylamine N-acetyltransferase 2.
od: Russell, A, i dr.
Izdano: (2009)

Comparison of the Arylamine N-acetyltransferase from Mycobacterium marinum and Mycobacterium tuberculosis.
od: Fullam, E, i dr.
Izdano: (2009)

Probing the architecture of the Mycobacterium marinum arylamine N-acetyltransferase active site.
od: Abuhammad, A, i dr.
Izdano: (2010)

Protein-ligand interactions of arylamine N-acetyltransferase from Mycobacterium smegmatis
od: Brooke, E
Izdano: (2003)

Polymorphisms of arylamine N-acetyltransferase2 and risk of lung and colorectal cancer
od: Amjad Mahasneh, i dr.
Izdano: (2012-01-01)

Arylamine N-Acetyltransferase 1 Activity is Regulated by the Protein Acetylation Status
od: Raúl A. Salazar-González, i dr.
Izdano: (2022-01-01)

Over-expression, purification, and characterization of recombinant human arylamine N-acetyltransferase 1.
od: Wang, H, i dr.
Izdano: (2005)

Eukaryotic arylamine N-acetyltransferase. Investigation of substrate specificity by high-throughput screening.
od: Kawamura, A, i dr.
Izdano: (2005)

Identification of arylamine N-acetyltransferase inhibitors as an approach towards novel anti-tuberculars.
od: Westwood, I, i dr.
Izdano: (2010)

Distribution of arylamine N-acetyltransferase 2 (NAT2) genotypes among Omanis
od: Musbah O. M. Tanira, i dr.
Izdano: (2003-04-01)

Characterization of the putative operon containing arylamine N-acetyltransferase (nat) in Mycobacterium bovis BCG.
od: Anderton, M, i dr.
Izdano: (2006)

Arylamine N-acetyltransferase 2 genotype-dependent N-acetylation of isoniazid in cryopreserved human hepatocytes
od: Mark A. Doll, i dr.
Izdano: (2017-07-01)

Characterization of the putative operon containing arylamine N−acetyltransferase (nat) in Mycobacterium bovis BCG
od: Eltis, E
Izdano: (2006)

Inhibition of mycobacterial arylamine N-acetyltransferase contributes to anti-mycobacterial activity of Warburgia salutaris.
od: Madikane, V, i dr.
Izdano: (2007)

Inhibition of mycobacterial arylamine N-acetyltransferase contributes to anti-mycobacterial activity of Warburgia salutaris
od: Madikane, V, i dr.
Izdano: (2007)

Synthesis and in vitro evaluation of novel small molecule inhibitors of bacterial arylamine N-acetyltransferases (NATs).
od: Brooke, E, i dr.
Izdano: (2003)

Novel small-molecule inhibitors of arylamine N-acetyltransferases: drug discovery by high-throughput screening.
od: Westwood, I, i dr.
Izdano: (2011)

Arylamine N-Acetyltransferases from mycobacteria: investigations of a potential yarget for anti-tubercular therapy
od: Abuhammad, A
Izdano: (2013)

Hamster arylamine N-acetyltransferase 2: Investigation of substrate specificity by high-through-put screening
od: Kawamura, A, i dr.
Izdano: (2004)

A pilot study of the modulation of sirtuins on arylamine N-acetyltransferase 1 and 2 enzymatic activity
od: Eneida Turiján-Espinoza, i dr.
Izdano: (2018-03-01)

Association of the cytochrome P450 and arylamine N-acetyltransferase gene polymorphisms with the incidence of head and neck cancer in Polish population
od: Monika Gogolewska, i dr.
Izdano: (2023-12-01)

Identification of new arylamine N-acetyltransferases and enhancing 2-acetamidophenol production in Pseudomonas chlororaphis HT66
od: Shuqi Guo, i dr.
Izdano: (2020-05-01)

Arylamine N-acetyltransferase-1 is highly expressed in breast cancers and conveys enhanced growth and resistance to etoposide in vitro.
od: Adam, P, i dr.
Izdano: (2003)

The structure of arylamine N-acetyltransferase from Mycobacterium smegmatis--an enzyme which inactivates the anti-tubercular drug, isoniazid.
od: Sandy, J, i dr.
Izdano: (2002)

Dataset for proteomic analysis of arylamine N-acetyltransferase 1 knockout MDA-MB-231 breast cancer cells
od: Kyung U. Hong, i dr.
Izdano: (2022-12-01)